Physician profile
Benjamin S Simon
NPI 1679550909
$650.74
in general payments reported to CMS, 2019-2025
11 companies · $371 in 2025
The $371 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.04 · 2021: $12.00 · 2022: $175 · 2024: $70.35 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.44 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $177.07 | 2022-2025 | Linq II |
| Heartflow, INC. | $166.64 | 2025 | |
| Irhythm Technologies, INC. | $70.35 | 2024 | Zio Xt Patch, Zio Monitor |
| Abbott Laboratories | $39.85 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Bardy Diagnostics, INC. | $37.00 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.65 | 2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $34.26 | 2025 | |
| Pfizer INC. | $29.32 | 2025 | |
| Medtronic Vascular, INC. | $22.04 | 2019 | |
| Esperion Therapeutics, INC. | $19.20 | 2025 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $18.36 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.